Bullboard - Stock Discussion Forum Arch Biopartners Inc V.ARCH

Alternate Symbol(s): ACHFF

Technology Scientific & Technical Instruments

Arch Biopartners Inc. is a late-stage clinical trial company focused on preventing acute kidney injury. The Company is developing a platform of new drugs to prevent inflammation injury in the kidneys, lungs and liver via the dipeptidase-1 (DPEP1) pathway and are relevant for many common injuries and diseases where organ inflammation is an unmet problem. The Company’s lead drug candidate is... see more

Add To Watchlist

TSXV:ARCH - Post Discussion

Arch Biopartners Inc > Terrific buying opportunity this morning

View:

Post by 2019champs on Oct 22, 2021 10:40am

Terrific buying opportunity this morning

We touched 2.46. Raymond james the big seller. Don't know why and don't care. More stronger hands the better!

128

Comment

Comment by GoldenArm on Oct 22, 2021 11:00am

Profit taking and I doubt they unloaded all their position.

Comment

Comment by stocksarefun on Oct 22, 2021 12:08pm

Intersting. From what I've heard through the grapevine, RJ has a buy analyst waiting for phase 3 results to initiate coverage on ARCH with a ~10$ buy target. Sounds like a classic acumulation strategy to me.

135

Comment

Comment by Antonius2 on Oct 22, 2021 5:34pm

Hi Stocksarefun, Do you know whether David Novak, Managing Director of Equity Research Analyst of Healthcare & Biotechnology at Raymond James name was mentioned in your grapevine?

Comment